PlainRecalls
FDA Drug Moderate Class II Terminated

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01

Reported: February 14, 2024 Initiated: January 15, 2024 #D-0319-2024

Product Description

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Details

Units Affected
858 bottles
Distribution
USA nationwide.
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01. Recalled by Amneal Pharmaceuticals of New York, LLC. Units affected: 858 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 14, 2024. Severity: Moderate. Recall number: D-0319-2024.